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Coronary artery spasm was first proposed as a cause of 
spontaneous, recurring angina1 attacks over a century ago 
(1). Because this brilliant clinical intuition could not be 
demonstrated at postmortem study, it fell into progressive 
disrepute until, in the early 1950s coronary artery spasm 
was considered “the resort of the diagnostically destitute” 
(2). In 1959, the notion of coronary artery spasm was bravely 
resurrected with clinjcal acumen by Prinzmetal et al. (3), and 
it became a proved hypothesis in the mid-1970s (4). 
Dynamic coronary artery stenoses caused by increased 
coronary tone, thrombosis or their combination are now 
recognized components of stable and unstable ischemic 
syndromes (5-g). Yet coronary artery spasm, as most typi- 
cally observed in variant angina, appears to be a rare 
condition with some rather unique features: it is usually 
localized to a segment of epicardia] coronary artery and 
causes transmural myocardial ischemia typically manifested 
by ST segment elevation, as documented during continuous 
electrocardiographic (ECG) monitoring. Coronary spasm 
tends to be transient and is usually promptly relieved by 
immediate administration of nitrates. In variant angina, it is 
usually episodic; patients may experience a waxing and 
waning of the disease for weeks, months and even years as 
spasm occurs spontaneously. Coronary spasm can be repro- 
duced by ergot derivatives and by hyperventilation. Many 
variations of this classical clinical picture can be encoun- 
tered, and it would be unwise to consider any single patho- 
genetic mechanism responsible for the whole spectrum 
of ischemic syndromes related to abnormal coronary 
vasoconstriction. 
The present study. In this issue of the Journal, Hoshio et 
al. (9) conclude that “a coronary vasomotion disorder, 
which involves increased basal coronary artery tone and 
hyperreactivity to vasoconstrictive stimuli, not only at a 
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localized segment but also of the entire coronary artery tree, 
is present in patients with vasospastic angina.” In our 
opinion, this conclusion requires qualification. 
The most striking finding in their study is the magnitude 
of coronary vasodilation observed proximal to the “spastic” 
segments and also in nonspastic arterial branches in the 
“vasospastic angina” group after the administration of ni- 
trates. Although confined to the “spastic” segments, 
marked dilation had been previously observed after nitrate 
administration in one study of white patients with typical 
variant angina (IO), but not in others (1 I, 12). Marked dilation 
of “nonspastic” segments after nitrates. however, was not 
previously observed in typical forms of variant angina, 
although it was noted occasionally in patients with other 
forms of coronary constriction (Fig. 10 of Maseri IS]). The 
extent of dilation observed in nonspastic segments in the 
Japanese “vasospastic angina” group is nearly double that 
commonly reported in whites (10-15). The extent of dilation 
found in the Japanese “nonvasospastic angina” group, how- 
ever, is slightly less than that found in whites (13-15). The 
extent of coronary constriction caused by ergonovine in 
whites is nearly double that in the Japanese control group, 
and of the same order of magnitude as that observed in 
nonspastic segments of the “vasospastic angina” group 
(1618). 
The findings of Hoshio et al. (9) should be considered in 
the light of the type of patients included in their “vasospastic 
angina” group. Unfortunately, insufficient information is 
provided on the clinical characteristics of their patients, such 
as type of angina, presence of spontaneous ST segment 
elevation during continuous ECG monitoring and results of 
exercise testing. It is of importance that only I3 of their 30 
patients with vasospastic angina developed ST segment 
elevation during ergonovine administration. Moreover, their 
criterion for defining coronary spasm (50% reduction of 
diameter, localized or diffuse) probably allowed the inclu- 
sion of patients (such as the one presented in Figure IO of 
Maseri [S]) who had no classical clinical features of variant 
angina and did not develop angina or ST segment elevation 
despite marked diffuse coronary constriction observed dur- 
ing ergonovine administration. Because data on individual 
patients are not presented in the study of Hoshio et al. (9), it 
is impossible to ascertain how many of the patients who 
developed ST segment elevation with ergonovine (and there- 
fore had at least one typical feature of variant angina) 
behaved like the average of the group. It is conceivable that 
their study patients as a whole are somewhat different from 
the patients with variant angina most commonly encoun- 
tered in Western countries. The dilation of nonspastic arte- 
rial segments caused by nitrates in their patients is of such a 
magnitude that it could not have passed unnoticed, if 
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present, in white patients with variant angina. The conclu- 
sion reached by Hoshio et al. certainly applies to the type of 
patients who were more prevalent in their possibly hetero- 
geneous study group, but it should not therefore be extrap 
elated to all patients with variant angina. Thus, we have 
some reservations as to the diagnostic value and ability of 
the angiographic findings described by Hoshio et al. (9) to 
predict the occurrence and location of coronary artery 
spasm in patients with variant angina. 
than one mechanism. Thus, it is wise to continue to patiently 
collect established facts rather than accept “unifying” 
pathogenetic hypotheses. Lumping together patients who 
may be heterogeneous could confuse rather than clarify the 
issue of the pathogenetic mechanisms of coronary artery 
spasm. It is hoped that properly collected data will eventu- 
ally all fit together like the tesserae of a mosaic to form a 
meaningful pattern. 
Pathogenesis of coronary artery spasm. After coronary 
artery spasm became a proved cause of variant angina, many 
pathogenetic hypotheses were put forward to explain the 
origin of this syndrome. Unfortunately, none has managed to 
stand the test of time. As suggested in 1976 (19). any 
pathogenetic hypothesis of variant angina should fit simple. 
common clinical observations such as the usual recurrence 
of spasm at the same arterial site and the possibility of 
reproducing spasm by a number of pharmacologic and 
physiologic tests that indicate a localized alteration of the 
arterial wall and a local susceptibility to constrictor stimuli. 
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